Lorenzl et al12 measured the levels of TIMP‐1 in CSF samples of patients with Parkinson's Disease, AD, Huntington's Disease and amyotrophic lateral sclerosis, and demonstrated that elevated TIMP‐1 levels were observed in all participants. This evidence concerns the gene TIMP1 and Parkinson disease.